Routine mammography for men?    Cancer dataset gets a boost    Cancer model metadata    High hopes for HERA    Taking aim at AML    Genes may regulate immunotherapy    TARDIS: A ‘game-changer’    Targeted RNA NGS for breast cancer    A break in the case    Proteins and cancer    Weaving a Tapestri in oncology    Rolling along with RET    Getting a two-year head start on cancer    An MEK and KRAS inhibitor collaboration    A cancer research collaboration    OSE receives grant from French National Research Agency    Encouraging results for endoxifen    Launch into oncology    A head-to-head trial in ASTS    Virtual R&D vs. cancer    ‘Eve of the revolution in cancer care’    Recurrence recommendation    More on the colorectal front    Getting ahead of head and neck cancer     Precigen begins Phase 1 PRGN-3005 study    Getting back to your roots    Ascentage Pharma brings HQP1351 to the U.S.    Next-generation grant    ‘Liquid’ assets    A good showing by Parsortix

	Special Focus on Immunology & Autoimmunity   Turn of the coin   Treading the edge between autoimmunity and oncology   Cancer Research News Feature   Drug launches and DALYs   Columbia Business School report examines how cancer drugs have impacted mortality for patients   Special Report on Cancer   Aiming for avatars   Oncologists seek clarity via patient-derived models
PAGE UTILITIES PRINT CURRENT PAGE SEND THIS PAGE TO A COLLEAGUE CONTACT US DDNEWS Published by Old River Publications LLC 19035 Old Detroit Road Rocky River, OH USA 44116 Ph: 440-331-6600  |  Fax: 440-331-7563

Home  |   About Us  |   Editor's Choice  |   News  |   Opinion  |   Top 5  |   Video  |   Links

© Copyright 2019 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.